Analyst Coverage

Investor Contacts

Katherine A. Littrell, PhD, RN
Vice President, Investor Relations

Diane H. Schrick
Senior Director, Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

Analyst Coverage

Jason Gerberry
Bank of America Merrill Lynch (BAML)
Gary Nachman
BMO Capital Markets
William Tanner
Cantor Fitzgerald
Liav Abraham
Citi
Ken Cacciatore
Cowen & Co.
Umer Raffat
Evercore ISI
David Buck
FBR Capital Markets
Dana Flanders
Goldman Sachs
Oren Livnat
H. C. Wainwright & Co., LLC
Jessica Fye
J.P. Morgan
Ken Trbovich
Janney
Ami Fadia
Leerink
Irina Koffler
Mizuho Securities
David Risinger
Morgan Stanley
Esther Rajavelu
Oppenheimer & Co. Inc.
David Amsellem
Piper Jaffray
Randall Stanicky
RBC Capital Markets
Aaron (Ronny) Gal
Sanford Bernstein
Annabel Samimy
Stifel
John Boris
Suntrust Robinson Humphrey
David Maris
Wells Fargo
Akash Tewari
Wolfe Research, LLC

Jazz Pharmaceuticals plc is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Jazz Pharmaceuticals plc's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Jazz Pharmaceuticals plc or its management. Jazz Pharmaceuticals plc does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.